KraneShares MSCI All China Health Care Index ETF
$19.00−0.34 (−1.76%)
- Expense ratio
- 0.79%
- Fund size
- $112M
- 1Y return
- −3.5%
- Yield · Last 12 months
- 3.70%
- Holdings
- 53
- Volume · 30D
- 0.1M sh
- NAV per share
- $19.08
- 52W range
The ETF.net KURE Grade
Score 20 of 100 sits in the F band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.FScore 10Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.FScore 9Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.FScore 24Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.CScore 52Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.DScore 38Category rank
Our read on KURE
FNearly every health care ETF on the shelf is a US pharma-and-devices basket. KURE points the other way: about 50 Chinese healthcare names, tracked through an MSCI China index, in one ticker.
KURE is designed to track the MSCI China All Shares Healthcare 10/40 Index, which represents Chinese companies engaged in the healthcare sector.
Why people hold it
- The exposure US sector funds skip. VHT, FHLC and XLV own American health care; KURE follows the MSCI China All Shares Healthcare 10/40 Index instead.
- Rules-based and compact: roughly 50 holdings set by a published MSCI index, not by a manager's conviction call.
- Trading since 2018 with moderate volume behind it, so this is a seasoned fund rather than a thin new launch chasing a theme.
Worth knowing
- 0.79% a year is specialist pricing. The big US health care index funds on the same shelf charge 0.08% (XLV, FHLC).
- One country, one sector. Chinese regulation, currency and market-access rules drive this fund in ways a US pharma basket never feels.
- A smaller fund than the sector giants, so spreads can run wider. Cash comes back once or twice a year, not monthly.
KURE Holdings
- Stocks
- 53
- 55%
- 1801.HK
Sectors
- Health Care99.1%
- Cons. Staples0.9%
Geography
- China83.32%
- Switzerland8.81%
- Hong Kong7.14%
- United States0.73%
Developed 16% · Emerging 84%
KURE Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | KURE |
|---|---|
| Year to date | +13.5% |
| 1 month | +1.2% |
| 3 months | +30.1% |
| 1 year | −3.5% |
| 3 years | +5.8% |
| 5 years | −8.7% |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | KURE |
|---|---|---|
| 2026 YTD | +13.5% | |
| 2025 | +24.9% | |
| 2024 | −17.8% | |
| 2023 | −17.7% | |
| 2022 | −25.4% | |
| 2021 | −15.8% | |
| 2020 | +69.0% |
KURE in the news
ETF.net Research hasn’t filed on KURE yet — coverage lands here as it’s written.
KURE Dividends
- 3.70%
- $0.71
- $0.71 per share
- Annual
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Dec 22, 2025 | Dec 23, 2025 | $0.71 |
| Dec 17, 2024 | Dec 18, 2024 | $0.18 |
| Dec 18, 2023 | Dec 20, 2023 | $0.11 |
| Dec 28, 2022 | Dec 30, 2022 | $0.01 |
| Dec 29, 2021 | Dec 31, 2021 | $4.05 |
| Dec 29, 2020 | Dec 31, 2020 | $0.00011 |
| Dec 27, 2019 | Dec 31, 2019 | $0.06 |
| Dec 26, 2018 | Dec 28, 2018 | $0.08 |
KURE Risk
- 26.0%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.10
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −60.0%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.44
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
KURE Cost
- The middle half of Health Care (Broad) funds
- Median 0.50%
21 of the 25 Health Care (Broad) funds charge less.